Our Terms of Service and Privacy Policy have changed.

By continuing to use this site, you are agreeing to the new Privacy Policy and Terms of Service.

Neptune Technologies & Bioressources Inc (NASDAQ:NEPT)

1.25
Delayed Data
As of May 27
 +0.0701 / +5.94%
Today’s Change
0.86
Today|||52-Week Range
1.52
+16.83%
Year-to-Date
Earnings Scheduled For May 25, 2016
May 25 / Benzinga - Paid Partner Content
 

Today’s Trading

Previous close1.18
Today’s open1.18
Day’s range1.18 - 1.27
Volume114,358
Average volume (3 months)92,411
Market cap$97.4M
Dividend yield--
Data as of 3:58pm ET, 05/27/2016

Growth & Valuation

Earnings growth (last year)-30.89%
Earnings growth (this year)+73.67%
Earnings growth (next 5 years)--
Revenue growth (last year)-28.12%
P/E ratio--
Price/Sales10.39
Price/Book1.91

Competitors

 Today’s
change
Today’s
% change
VBLTVascular Biogenics L...-0.01-0.27%
OASMOasmia Pharmaceutica...-0.03-0.64%
DNAIProNAi Therapeutics ...-0.58-9.06%
BGNEBeiGene Ltd-0.32-1.16%
Data as of 3:59pm ET, 05/27/2016

Financials

Next reporting date--
EPS forecast (this quarter)--
Annual revenue (last year)$13.4M
Annual profit (last year)-$24.8M
Net profit margin-185.54%

Profile

Sector
Process Industries
Industry
Chemicals: Specialty
President, Chief Executive Officer &
Director
James Hamilton
Chief Financial Officer
Mario Paradis
Corporate headquarters
Laval, Quă©bec

Forecasts

Partner Offers

Search for Jobs